vs
Antero Midstream Corp（AM）与GE医疗（CCRN）财务数据对比。点击上方公司名可切换其他公司
Antero Midstream Corp的季度营收约是GE医疗的1.2倍（$291.1M vs $236.8M），Antero Midstream Corp净利率更高（41.5% vs -35.0%，领先76.5%），Antero Midstream Corp同比增速更快（-7.3% vs -23.6%），过去两年Antero Midstream Corp的营收复合增速更高（3.9% vs -21.0%）
Antero Midstream Corp是美国能源企业，注册地为特拉华州，总部设于科罗拉多州丹佛市。公司全部油气储量均位于阿巴拉契亚盆地，采用水力压裂技术开采，核心业务涵盖油气勘探开发相关领域。
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，品牌标识为GE HealthCare。公司主要业务分为四大板块：包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务，以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务，此外还开展医药相关业务。
AM vs CCRN — 直观对比
营收规模更大
AM
是对方的1.2倍
$236.8M
营收增速更快
AM
高出16.3%
-23.6%
净利率更高
AM
高出76.5%
-35.0%
两年增速更快
AM
近两年复合增速
-21.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $291.1M | $236.8M |
| 净利润 | $120.7M | $-82.9M |
| 毛利率 | — | — |
| 营业利润率 | 60.9% | -30.2% |
| 净利率 | 41.5% | -35.0% |
| 营收同比 | -7.3% | -23.6% |
| 净利润同比 | 2.1% | -2109.7% |
| 每股收益（稀释后） | $0.25 | $-2.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMCCRN
| Q1 26 | $291.1M | — | ||
| Q4 25 | $297.0M | $236.8M | ||
| Q3 25 | $294.8M | $250.1M | ||
| Q2 25 | $305.5M | $274.1M | ||
| Q1 25 | $291.1M | $293.4M | ||
| Q4 24 | $287.5M | $309.9M | ||
| Q3 24 | $269.9M | $315.1M | ||
| Q2 24 | $269.8M | $339.8M |
净利润AMCCRN
| Q1 26 | $120.7M | — | ||
| Q4 25 | $51.9M | $-82.9M | ||
| Q3 25 | $116.0M | $-4.8M | ||
| Q2 25 | $124.5M | $-6.7M | ||
| Q1 25 | $120.7M | $-490.0K | ||
| Q4 24 | $111.2M | $-3.8M | ||
| Q3 24 | $99.7M | $2.6M | ||
| Q2 24 | $86.0M | $-16.1M |
毛利率AMCCRN
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 20.4% | ||
| Q2 25 | — | 20.4% | ||
| Q1 25 | — | 20.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 20.4% | ||
| Q2 24 | — | 20.8% |
营业利润率AMCCRN
| Q1 26 | 60.9% | — | ||
| Q4 25 | 33.8% | -30.2% | ||
| Q3 25 | 61.2% | -2.4% | ||
| Q2 25 | 61.0% | -2.1% | ||
| Q1 25 | 60.9% | -0.3% | ||
| Q4 24 | 61.8% | -1.1% | ||
| Q3 24 | 60.2% | 0.9% | ||
| Q2 24 | 56.6% | -5.7% |
净利率AMCCRN
| Q1 26 | 41.5% | — | ||
| Q4 25 | 17.5% | -35.0% | ||
| Q3 25 | 39.3% | -1.9% | ||
| Q2 25 | 40.8% | -2.4% | ||
| Q1 25 | 41.5% | -0.2% | ||
| Q4 24 | 38.7% | -1.2% | ||
| Q3 24 | 37.0% | 0.8% | ||
| Q2 24 | 31.9% | -4.7% |
每股收益（稀释后）AMCCRN
| Q1 26 | $0.25 | — | ||
| Q4 25 | $0.11 | $-2.56 | ||
| Q3 25 | $0.24 | $-0.15 | ||
| Q2 25 | $0.26 | $-0.20 | ||
| Q1 25 | $0.25 | $-0.02 | ||
| Q4 24 | $0.23 | $-0.13 | ||
| Q3 24 | $0.21 | $0.08 | ||
| Q2 24 | $0.18 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.4M | $108.7M |
| 总债务越低越好 | $3.2B | — |
| 股东权益账面价值 | $2.0B | $322.8M |
| 总资产 | $5.9B | $449.0M |
| 负债/权益比越低杠杆越低 | 1.63× | — |
8季度趋势，按日历期对齐
现金及短期投资AMCCRN
| Q1 26 | $180.4M | — | ||
| Q4 25 | $180.4M | $108.7M | ||
| Q3 25 | — | $99.1M | ||
| Q2 25 | — | $81.2M | ||
| Q1 25 | — | $80.7M | ||
| Q4 24 | — | $81.6M | ||
| Q3 24 | — | $64.0M | ||
| Q2 24 | — | $69.6M |
总债务AMCCRN
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.0B | — | ||
| Q2 25 | $3.0B | — | ||
| Q1 25 | $3.1B | — | ||
| Q4 24 | $3.1B | — | ||
| Q3 24 | $3.2B | — | ||
| Q2 24 | $3.2B | — |
股东权益AMCCRN
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $322.8M | ||
| Q3 25 | $2.1B | $408.1M | ||
| Q2 25 | $2.1B | $412.2M | ||
| Q1 25 | $2.1B | $418.2M | ||
| Q4 24 | $2.1B | $419.0M | ||
| Q3 24 | $2.1B | $424.7M | ||
| Q2 24 | $2.1B | $433.3M |
总资产AMCCRN
| Q1 26 | $5.9B | — | ||
| Q4 25 | $5.9B | $449.0M | ||
| Q3 25 | $5.7B | $538.2M | ||
| Q2 25 | $5.7B | $553.8M | ||
| Q1 25 | $5.8B | $576.2M | ||
| Q4 24 | $5.8B | $589.3M | ||
| Q3 24 | $5.8B | $597.4M | ||
| Q2 24 | $5.8B | $602.9M |
负债/权益比AMCCRN
| Q1 26 | 1.63× | — | ||
| Q4 25 | 1.63× | — | ||
| Q3 25 | 1.46× | — | ||
| Q2 25 | 1.45× | — | ||
| Q1 25 | 1.49× | — | ||
| Q4 24 | 1.47× | — | ||
| Q3 24 | 1.49× | — | ||
| Q2 24 | 1.50× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $198.9M | $18.2M |
| 自由现金流经营现金流 - 资本支出 | — | $16.1M |
| 自由现金流率自由现金流/营收 | — | 6.8% |
| 资本支出强度资本支出/营收 | 11.1% | 0.9% |
| 现金转化率经营现金流/净利润 | 1.65× | — |
| 过去12个月自由现金流最近4个季度 | — | $40.1M |
8季度趋势，按日历期对齐
经营现金流AMCCRN
| Q1 26 | $198.9M | — | ||
| Q4 25 | $255.5M | $18.2M | ||
| Q3 25 | $212.8M | $20.1M | ||
| Q2 25 | $265.2M | $4.2M | ||
| Q1 25 | $198.9M | $5.7M | ||
| Q4 24 | $232.7M | $24.2M | ||
| Q3 24 | $184.9M | $7.5M | ||
| Q2 24 | $215.8M | $82.4M |
自由现金流AMCCRN
| Q1 26 | — | — | ||
| Q4 25 | — | $16.1M | ||
| Q3 25 | — | $17.9M | ||
| Q2 25 | — | $2.3M | ||
| Q1 25 | — | $3.8M | ||
| Q4 24 | — | $21.7M | ||
| Q3 24 | $184.3M | $6.3M | ||
| Q2 24 | $147.2M | $79.6M |
自由现金流率AMCCRN
| Q1 26 | — | — | ||
| Q4 25 | — | 6.8% | ||
| Q3 25 | — | 7.2% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | 68.3% | 2.0% | ||
| Q2 24 | 54.6% | 23.4% |
资本支出强度AMCCRN
| Q1 26 | 11.1% | — | ||
| Q4 25 | — | 0.9% | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | 0.0% | 0.8% | ||
| Q3 24 | 0.2% | 0.4% | ||
| Q2 24 | 25.4% | 0.8% |
现金转化率AMCCRN
| Q1 26 | 1.65× | — | ||
| Q4 25 | 4.92× | — | ||
| Q3 25 | 1.84× | — | ||
| Q2 25 | 2.13× | — | ||
| Q1 25 | 1.65× | — | ||
| Q4 24 | 2.09× | — | ||
| Q3 24 | 1.85× | 2.92× | ||
| Q2 24 | 2.51× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AM
| Gathering and compression–Antero Resources | $238.0M | 82% |
| Other | $52.3M | 18% |
| Water handling–third party | $505.0K | 0% |
| Gathering and compression–third party | $295.0K | 0% |
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
